Compounds > (2r,3s)-3-(4-amino-1h-imidazo(4,5-c)pyridin-1-yl)-2-nonanol
Page last updated: 2024-12-10
(2r,3s)-3-(4-amino-1h-imidazo(4,5-c)pyridin-1-yl)-2-nonanol
Description
**(2r,3s)-3-(4-amino-1h-imidazo(4,5-c)pyridin-1-yl)-2-nonanol** is a complex organic molecule with a specific stereochemical configuration. Let's break down its structure and potential importance in research:
**Structure:**
* **(2r,3s)-:** This designation indicates the absolute configuration of the chiral centers at positions 2 and 3. The 'r' and 's' notations are used in the Cahn-Ingold-Prelog system to describe the spatial arrangement of atoms around a chiral center.
* **3-(4-amino-1h-imidazo(4,5-c)pyridin-1-yl)-:** This part describes a substituted imidazopyridine ring.
* Imidazopyridine is a bicyclic heterocyclic compound with a nitrogen-containing ring fused to a pyridine ring.
* 4-amino indicates an amino (-NH2) group attached to the fourth position of the imidazopyridine ring.
* 1-yl signifies that the imidazopyridine ring is attached to the rest of the molecule through the nitrogen atom at position 1.
* **2-nonanol:** This indicates a nonanol molecule (a nine-carbon alcohol) with the hydroxyl group (-OH) attached at the second carbon.
**Importance in Research:**
The importance of this specific compound depends on its potential biological activity. While I don't have access to specific research publications on this molecule, its structure suggests potential for:
* **Pharmacological activity:**
* Imidazopyridines are often associated with various biological activities, including anti-inflammatory, antiviral, and antitumor properties.
* The specific structure and configuration of this compound could lead to unique interactions with biological targets.
* **Ligand development:**
* The imidazopyridine ring, along with the nonanol side chain, could be modified to create ligands (molecules that bind to specific targets) for various receptors or enzymes.
* **Chemical probe development:**
* The compound could be used to study specific biochemical pathways or processes related to the targets it interacts with.
**To understand the precise importance of this molecule, you would need to:**
* **Consult scientific literature:** Look for research publications that mention this specific compound or its analogs.
* **Determine the target of interest:** Identify the specific protein or biological pathway that the molecule interacts with.
* **Investigate its biological activity:** Explore the potential effects of the molecule on the target and any associated biological processes.
**Remember, understanding the importance of a molecule requires in-depth research and analysis.**
(2R,3S)-3-(4-Amino-1H-imidazo(4,5-c)pyridin-1-yl)-2-nonanol: InChIKey: DAWSASDELFSMFB-NEPJUHHUSA-N [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 3036121 |
MeSH ID | M0120727 |
Synonyms (15)
Synonym |
1h-imidazo(4,5-c)pyridine-1-ethanol, 4-amino-beta-hexyl-alpha-methyl-, (r*,s*)-(+-)- |
4-amino-1-(2-hydroxy-3-nonyl)-1h-imidazo(4,5-c)pyridine |
erythro-9-(2-hydroxy-3-nonyl)-3-deazaadenine |
(2r,3s)-3-(4-amino-1h-imidazo(4,5-c)pyridin-1-yl)-2-nonanol |
9frf2zj35m , |
87871-09-8 |
unii-9frf2zj35m |
3-deaza-ehna |
hwc-09 |
1h-imidazo(4,5-c)pyridine-1-ethanol, 4-amino-.beta.-hexyl-.alpha.-methyl-, (r*,s*)- |
1h-imidazo(4,5-c)pyridine-1-ethanol, 4-amino-.beta.-hexyl-.alpha.-methyl-, (.alpha.r,.beta.s)-rel- |
9-(2-hydroxy-3-nonyl)-3-deazaadenine, erythro- |
9-(2-hydroxy-3-nonyl)-3-deazaadenine |
DTXSID90236674 |
Q27272496 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.38
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.38 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |